{"title": "An mRNA vaccine delivered in hydrogel shows promise as a durable cancer immunotherapy", "author": "Angus Liu", "url": "https://www.fiercebiotech.com/research/mrna-vaccine-delivered-hydrogel-shows-promise-as-a-durable-cancer-immunotherapy", "hostname": "fiercebiotech.com", "description": "Before mRNA vaccines became valuable preventive tools against COVID-19, scientists around the world were studying the technology's potential use in cancer therapeutics, but their | Scientists at China's National center for Nanoscience and Technology have designed a hydrogel to deliver an mRNA vaccine with an immune-stimulating adjuvant. When injected into mice with melanoma, the vaccine stayed active for at least 30 days, inhibiting tumor growth and preventing metastasis.", "sitename": "FierceBiotech", "date": "2021-02-17", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}